A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19 F and 31 P magnetic resonance spectroscopy

By McSheehy P.M.J.   Seymour M.T.   Ojugo A.S.E.   Rodrigues L.M.   Leach M.O.   Judson I.R.   Griffiths J.R.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2418-2427

Elsevier

Access to resources Recommend Favorite

Uptake and retention of nitroimidazole-carboranes designed for boron neutron capture therapy in experimental murine tumours: 11 detection by B magnetic resonance spectroscopy

By Wood P. J.   Scobie M.   Threadgill M. D.  

International Journal of Radiation Biology, Vol. 70, Iss. 5, 1996-11 ,pp. : 587-592

Informa Healthcare

Access to resources Recommend Favorite

Magnetic Resonance Spectroscopic Imaging (¹H-MRSI) and Dynamic Contrast-Enhanced Magnetic Resonance (DCE-MRI): Pattern Changes From Inflammation to Prostate Cancer

By Sciarra Alessandro   Panebianco Valeria   Ciccariello Mauro   Salciccia Stefano   Lisi Danilo   Osimani Marcello   Alfarone Andrea   Gentilucci Alessandro   Parente Ulderico   Passariello Roberto   Gentile Vincenzo  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 424-432

Informa Healthcare

Access to resources Recommend Favorite

Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients

By        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 321-328

Spandidos Publications

Access to resources Recommend Favorite

The contribution of Magnetic Resonance Spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours

By Fayed Nicolás   Modrego Pedro  

Journal of Neuro-Oncology, Vol. 72, Iss. 3, 2005-05 ,pp. : 261-265

Springer Publishing Company

Access to resources Recommend Favorite